Abbott Laboratories completed its acquisition of Exact Sciences Corporation on March 23, 2026, pursuant to the Merger Agreement dated November 19, 2025. Each share of Exact Sciences common stock was converted into the right to receive $105.00 in cash, and Exact Sciences became a direct, wholly owned subsidiary of Abbott.
Key takeaways
Abbott completed acquisition of Exact Sciences Corporation on March 23, 2026
Merger Agreement dated November 19, 2025, by and among Abbott, Exact Sciences, and Badger Merger Sub I, Inc.
Merger Sub merged with and into Exact Sciences, with Exact surviving as wholly owned subsidiary
Exact Sciences common stock converted to $105.00 in cash per share at Effective Time
Last day of trading for Exact Sciences shares on Nasdaq: March 20, 2026
Press release issued as Exhibit 99.1 announcing closing